NDC 70518-4541-00 - Metoclopramide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4541
- Requested NDC
- 70518-4541-00
- Package NDCs from labels
- 70518-4541-0, 70518-4541-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metoclopramide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4541-0 | Metoclopramide | 40 in 1 BOTTLE, PLASTIC | TABLET | 40 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoclopramide | METOCLOPRAMIDE | Coupler LLC | 5345a125-0cee-472e-e063-6394a90aeb21 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | 311668 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Safecor Health LLC | 15d616d7-2f4c-4882-a03c-fcc86c18f5f8 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 146803a1-199d-4789-b128-e974bdd03322 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | REMEDYREPACK INC. | 6637cb78-d50a-4dbf-8fb7-b1b5102c5c5f | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | ANI Pharmaceuticals, Inc. | 797aad80-0597-42f8-99d5-39de180c3b5a | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | NDA017854 62559-296 311668 311666 6d4ed2af-6756-4e7a-8325-820490408f5f 797aad80-0597-42f8-99d5-39de180c3b5a W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | ScieGen Pharmaceuticals, Inc. | b16ad17c-eeea-407e-91e4-36506e9aa698 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 50a3cf38-66dc-4fa5-8a45-adf959c987ab | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | cccf04bd-7463-40b8-a41f-cb1093c358d7 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Metoclopramide | METOCLOPRAMIDE | Teva Parenteral Medicines, Inc. | 5645a752-8868-4b51-8b59-48bb4276d763 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| METOCLOPRAMIDE | METOCLOPRAMIDE | HF Acquisition Co LLC, DBA HealthFirst | 4046830f-4b87-5e6e-e063-6394a90aeeb8 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Hospira, Inc. | 373ba08b-33ad-49fc-28a7-928e89a65314 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Teva Pharmaceuticals USA, Inc. | e15905e0-e0f6-4c8b-ac19-59724d6c4bf0 | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| GIMOTI | METOCLOPRAMIDE HYDROCHLORIDE | Evoke Pharma, Inc. | 95269b1f-779c-4ca0-9f86-e74e677f9900 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Reglan | METOCLOPRAMIDE HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | de55c133-eb08-4a35-91a2-5dc093027397 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | NDA017854 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Redpharm Drug | 49eb807b-fa34-3d84-e063-6394a90acfcf | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | NDA017854 311668 W1792A2RVD |
| metoclopramide hydrochloride | METOCLOPRAMIDE HYDROCHLORIDE | Chartwell RX, LLC | dc364325-dd39-4259-a348-3760eccdca4b | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | AvKARE | ff067ac5-6efc-3e86-e6d5-590b2779491c | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 311668 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | Northwind Health Company, LLC | f2b732ab-b859-7252-e053-2995a90af0d8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 311666 W1792A2RVD |
| Metoclopramide | METOCLOPRAMIDE | NuCare Pharmaceuticals, Inc. | 4524146c-f588-083b-e063-6294a90ac977 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 311668 W1792A2RVD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.